ArticleCancer research2023

Targeting CD44 Variant 5 with an Antibody-Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma.

Yuncheng Bei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.